Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland.
FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...
But now, Abbott’s FreeStyle Libre 2 and 3 have received the first and only FDA clearance that allows patients to keep their ...
A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide an automatic ...
GlobalData on MSN2mon
FDA hits Abbott FreeStyle Libre 3 recall with Class I tagThe US Food and Drug Administration (FDA) has tagged Abbott’s recent recall of its faulty FreeStyle Libre 3 sensors as Class ...
The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...
[Harley] decided not to wait and managed to interface an Abbot FreeStyle Libre sensor with the Apple watch. The sensor doesn’t directly read glucose continuously, but it does allow for more ...
Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback